JP2022529535A5 - - Google Patents

Info

Publication number
JP2022529535A5
JP2022529535A5 JP2021563229A JP2021563229A JP2022529535A5 JP 2022529535 A5 JP2022529535 A5 JP 2022529535A5 JP 2021563229 A JP2021563229 A JP 2021563229A JP 2021563229 A JP2021563229 A JP 2021563229A JP 2022529535 A5 JP2022529535 A5 JP 2022529535A5
Authority
JP
Japan
Prior art keywords
agent
drug
stem cells
pesc
eso
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021563229A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022529535A (ja
JP7650243B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/029933 external-priority patent/WO2020219963A1/en
Publication of JP2022529535A publication Critical patent/JP2022529535A/ja
Publication of JP2022529535A5 publication Critical patent/JP2022529535A5/ja
Application granted granted Critical
Publication of JP7650243B2 publication Critical patent/JP7650243B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021563229A 2019-04-26 2020-04-24 上皮組織の慢性炎症性傷害、化生、異形成、及びがんを治療するための方法ならびに組成物 Active JP7650243B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962839152P 2019-04-26 2019-04-26
US62/839,152 2019-04-26
US201962924978P 2019-10-23 2019-10-23
US62/924,978 2019-10-23
PCT/US2020/029933 WO2020219963A1 (en) 2019-04-26 2020-04-24 Methods and compositions for treating chronic inflammatory injury, metaplasia, dysplasia and cancers of epithelial tissues

Publications (3)

Publication Number Publication Date
JP2022529535A JP2022529535A (ja) 2022-06-22
JP2022529535A5 true JP2022529535A5 (https=) 2023-04-28
JP7650243B2 JP7650243B2 (ja) 2025-03-24

Family

ID=72941789

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021563229A Active JP7650243B2 (ja) 2019-04-26 2020-04-24 上皮組織の慢性炎症性傷害、化生、異形成、及びがんを治療するための方法ならびに組成物

Country Status (9)

Country Link
US (1) US20220202792A1 (https=)
EP (1) EP3962559B1 (https=)
JP (1) JP7650243B2 (https=)
KR (1) KR20220007867A (https=)
CN (1) CN114007671B (https=)
AU (1) AU2020263577B2 (https=)
CA (1) CA3135020A1 (https=)
IL (1) IL287573A (https=)
WO (1) WO2020219963A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4117718A4 (en) * 2020-03-09 2024-05-08 University of Houston System INFLAMMATORY BOWEL DISEASE (IBD)-ASSOCIATED STEM CELLS, AGENTS TARGETING IBD-ASSOCIATED STEM CELLS AND RELATED USES THEREOF
EP4121111A4 (en) * 2020-03-20 2024-05-15 University of Houston System METHODS AND COMPOSITIONS FOR THE TREATMENT OF INFLAMMATORY AND FIBROTIC LUNG DISEASES
JP2024504378A (ja) * 2021-01-25 2024-01-31 アトス セラピューティクス,インコーポレイテッド トリアジン化合物ならびにこれを作製する方法および使用する方法
MX2024004848A (es) * 2021-10-22 2024-07-15 Univ Houston System Metodos y composiciones para el tratamiento de lesiones inflamatorias cronicas, metaplasias, displasia y canceres de tejidos epiteliales.
WO2025212580A1 (en) * 2024-04-01 2025-10-09 Xdc Precision Therapeutics Llc Antibody-kras binder conjugates, pharmaceutical compositions, and therapeutic applications
WO2025253352A1 (en) * 2024-06-07 2025-12-11 Consejo Nacional De Investigaciones Cientificas Y Tecnicas (Conicet) Methods for promoting hepatic regeneration

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9393396B2 (en) * 2002-02-14 2016-07-19 Gholam A. Peyman Method and composition for hyperthermally treating cells
US20160166683A1 (en) * 2009-12-15 2016-06-16 lseu da Silva NUNES Adjuvant immunotherapy for the treatment cancer, of clinical manifestations associated with the diseases like cachexia and correction of adverse effects of drugs such as immunosuppression, secundary cachexia, neutropenia and lymphopenia, comprising the association or combination of a biological response modifier specially selected and other substances with antineoplastic action and/or other treatments
US20120010230A1 (en) * 2010-07-08 2012-01-12 Macdougall John R Methods and compositions for identification, assessment and treatment of cancers associated with hedgehog signaling
WO2012044992A2 (en) * 2010-09-30 2012-04-05 Agency For Science, Technology And Research (A*Star) Methods and reagents for detection and treatment of esophageal metaplasia
US9339516B2 (en) * 2011-05-06 2016-05-17 Lankenau Institute For Medical Research Compositions and methods for the prevention of esophageal cancer
HK1202333A1 (en) 2011-11-11 2015-09-25 Intellikine, Llc Combination of kinase inhibitors and uses thereof
CA2868302A1 (en) * 2012-03-23 2013-09-26 Dennis M. Brown Compositions and methods to improve the therapeutic benefit of indirubin and analogs thereof, including meisoindigo
HUE045065T2 (hu) * 2014-01-31 2019-12-30 Novartis Ag TIM-3 antitest molekulák és felhasználásaik
WO2015158809A1 (en) * 2014-04-17 2015-10-22 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of cancer
KR20170060042A (ko) * 2014-09-13 2017-05-31 노파르티스 아게 Alk 억제제의 조합 요법
ES2913048T3 (es) * 2015-09-21 2022-05-31 Opna Immuno Oncology Sa Compuestos heterocíclicos y usos de estos
CN105457038A (zh) * 2015-11-09 2016-04-06 东南大学 一种速释型药物磷脂化合物及其药物组合物
WO2017190009A1 (en) 2016-04-29 2017-11-02 The Board Of Regents Of The University Of Texas System Use of jumonji c demethylase inhibitors for the treatment and prevention of chemotherapy resistance and radioresistance in cancer
US12208287B2 (en) * 2017-05-05 2025-01-28 University Of Houston System Inflammatory bowel disease stem cells, agents which target IBD stem cells, and uses related thereto

Similar Documents

Publication Publication Date Title
JP2022529535A5 (https=)
JP6770157B2 (ja) 特定の投薬量の活性物質を皮膚又は粘膜に投与するための電気流体力学的に得られた繊維を含む組成物
KR102001163B1 (ko) 전기수력학적으로 수득된 섬유를 포함하는 약학적 조성물, 적용 부위에서 향상된 체류 시간을 갖는 조성물
ES2742525T3 (es) Composiciones de corticosteroides administradas oralmente
JP2005506367A5 (https=)
EP2656860A1 (en) Topical vasoconstrictor preparations and methods for protecting cells during cancer chemotherapy and radiotherapy
JP2010265319A (ja) 粘膜表面への、薬剤化合物の送達に適する薬剤キャリアデバイス
JP2002536319A (ja) 局所用スプレー
WO2001047559A1 (fr) Pastilles a usage externe
CN105431175A (zh) 透皮递送系统
JP2006528604A5 (https=)
WO2016079246A1 (en) Bioadhesive films
KR20060130747A (ko) 약제의 제조 방법
JPH09315964A (ja) 肩こり・五十肩治療用貼付剤
KR100806541B1 (ko) 아세클로페낙을 함유하는 제어 방출성 제제
CN118055760A (zh) 具有可调释放曲线的可植入贮库
CN117503689A (zh) 一种抑制早期瘢痕增生的纳米凝胶及其制备方法
JPH01131115A (ja) クレボプリド経皮貼付剤
JPH09118619A (ja) 放射線障害予防・治療剤
HK1235690B (en) Compositions comprising electrohydrodynamically obtained fibres for administration of specific dosages of an active substance to skin or mucosa
HK1235690A1 (en) Compositions comprising electrohydrodynamically obtained fibres for administration of specific dosages of an active substance to skin or mucosa